UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 10-Q
(Mark One)
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended March 29, 2014
or
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from to
Commission File Number: 000-10030
APPLE INC.
(Exact name of Registrant as specified in its charter)
California
94-2404110
(State or other jurisdiction
of incorporation or organization)
(I.R.S. Employer Identification No.)
1 Infinite Loop
Cupertino, California
95014
(Address of principal executive offices)
(Zip Code)
(408) 996-1010
(Registrant s telephone number, including area code)
Indicate by
check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to
file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Yes No
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule
405 of Regulation S-T ( 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).
Yes No
Indicate by check mark whether the registrant is a large accelerated filer,
an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of large accelerated filer, accelerated filer and smaller reporting company in Rule 12b-2 of the Exchange Act.
Large accelerated filer
Accelerated filer
Non-accelerated filer
(Do not check if a smaller reporting company)
Smaller reporting company
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
Yes No
861,381,000 shares of common stock, par value $0.00001, issued and outstanding as
of April 11, 2014
Table of Contents
Apple Inc.
Form 10-Q
For the Fiscal Quarter Ended March 29, 2014
TABLE OF CONTENTS
Page
Part I
Item 1.
Financial Statements
Item 2.
Management s Discussion and Analysis of Financial Condition and Results of
Operations
23
Item 3.
Quantitative and Qualitative Disclosures About Market Risk
37
Item 4.
Controls and Procedures
37
Part II
Item 1.
Legal Proceedings
38
Item 1A.
Risk Factors
39
Item 2.
Unregistered Sales of Equity Securities and Use of Proceeds
49
Item 3.
Defaults Upon Senior Securities
49
Item 5.
Other Information
49
Item 6.
Exhibits
50
Table of Contents
PART I. FINANCIAL INFORMATION
Item 1.
Financial Statements
APPLE INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)
(In millions, except number of shares which are reflected in thousands and per share amounts)
Three Months Ended
Six Months Ended
March 29,
2014
March 30,
2013
March 29,
2014
March 30,
2013
Net sales
45,646
43,603
103,240
98,115
Cost of sales
27,699
27,254
63,447
60,706
Gross margin
17,947
16,349
39,793
37,409
Operating expenses:
Research and development
1,422
1,119
2,752
2,129
Selling, general and administrative
2,932
2,672
5,985
5,512
Total operating expenses
4,354
3,791
8,737
7,641
Operating income
13,593
12,558
31,056
29,768
Other income/(expense), net
225
347
471
809
Income before provision for income taxes
13,818
12,905
31,527
30,577
Provision for income taxes
3,595
3,358
8,232
7,952
Net income
10,223
9,547
23,295
22,625
Earnings per share:
Basic
11.69
10.16
26.31
24.09
Diluted
11.62
10.09
26.16
23.90
Shares used in computing earnings per share:
Basic
874,757
939,629
885,415
939,273
Diluted
879,528
946,035
890,490
946,626
Cash dividends declared per common share
3.05
2.65
6.10
5.30
See accompanying Notes to Condensed Consolidated Financial Statements.
Table of Contents
APPLE INC.
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Unaudited)
(In millions)
Three Months Ended
Six Months Ended
March 29,
2014
March 30,
2013
March 29,
2014
March 30,
2013
Net income
10,223
9,547
23,295
22,625
Other comprehensive income/(loss):
Change in foreign currency translation, net of tax
(19
(51
(86
(77
Change in unrecognized gains/losses on derivative instruments:
Change in fair value of derivatives, net of tax
(109
457
104
603
Adjustment for net (gains)/losses realized and included in net income, net of tax
(13
42
59
154
Total change in unrecognized gains/losses on derivative instruments, net of tax
(122
499
163
757
Change in unrealized gains/losses on marketable securities:
Change in fair value of marketable securities, net of tax
235
(52
193
(118
Adjustment for net (gains)/losses realized and included in net income, net of tax
(39
(44
(50
(97
Total change in unrealized gains/losses on marketable securities, net of tax
196
(96
143
(215
Total other comprehensive income/(loss)
55
352
220
465
Total comprehensive income
10,278
9,899
23,515
23,090
See accompanying Notes to Condensed Consolidated Financial Statements.
Table of Contents
APPLE INC.
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)
(In millions, except number of shares which are reflected in thousands)
March 29,
2014
September 28,
2013
ASSETS:
Current assets:
Cash and cash equivalents
18,949
14,259
Short-term marketable securities
22,401
26,287
Accounts receivable, less allowances of $88 and $99, respectively
9,700
13,102
Inventories
1,829
1,764
Deferred tax assets
4,014
3,453
Vendor non-trade receivables
6,120
7,539
Other current assets
7,528
6,882
Total current assets
70,541
73,286
Long-term marketable securities
109,239
106,215
Property, plant and equipment, net
15,120
16,597
Goodwill
2,055
1,577
Acquired intangible assets, net
3,928
4,179
Other assets
5,106
5,146
Total assets
205,989
207,000
LIABILITIES AND SHAREHOLDERS EQUITY:
Current liabilities:
Accounts payable
18,914
22,367
Accrued expenses
15,984
13,856
Deferred revenue
8,310
7,435
Total current liabilities
43,208
43,658
Deferred revenue non-current
3,164
2,625
Long-term debt
16,962
16,960
Other non-current liabilities
22,476
20,208
Total liabilities
85,810
83,451
Commitments and contingencies
Shareholders equity:
Common stock and additional paid-in capital, $0.00001 par value: 1,800,000 shares authorized; 861,745 and 899,213 shares issued
and outstanding, respectively
21,496
19,764
Retained earnings
98,934
104,256
Accumulated other comprehensive income/(loss)
(251
(471
Total shareholders equity
120,179
123,549
Total liabilities and shareholders equity
205,989
207,000
See accompanying Notes to Condensed Consolidated Financial Statements.
Table of Contents
APPLE INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)
(In millions)
Six Months Ended
March 29,
2014
March 30,
2013
Cash and cash equivalents, beginning of the period
14,259
10,746
Operating activities:
Net income
23,295
22,625
Adjustments to reconcile net income to cash generated by operating activities:
Depreciation and amortization
4,031
3,280
Share-based compensation expense
1,377
1,120
Deferred income tax expense
2,059
1,957
Changes in operating assets and liabilities:
Accounts receivable, net
3,401
3,846
Inventories
(65
(454
Vendor non-trade receivables
1,419
1,510
Other current and non-current assets
14
1,269
Accounts payable
(2,375
(4,422
Deferred revenue
1,414
1,541
Other current and non-current liabilities
1,638
3,658
Cash generated by operating activities
36,208
35,930
Investing activities:
Purchases of marketable securities
(90,360
(81,163
Proceeds from maturities of marketable securities
10,869
9,243
Proceeds from sales of marketable securities
80,241
49,188
Payments made in connection with business acquisitions, net
(559
(299
Payments for acquisition of property, plant and equipment
(3,367
(4,325
Payments for acquisition of intangible assets
(163
(429
Other
(23
(93
Cash used in investing activities
(3,362
(27,878
Financing activities:
Proceeds from issuance of common stock
341
275
Excess tax benefits from equity awards
363
502
Taxes paid related to net share settlement of equity awards
(430
(588
Dividends and dividend equivalents paid
(5,430
(4,984
Repurchase of common stock
(23,000
(1,950
Cash used in financing activities
(28,156
(6,745
Increase in cash and cash equivalents
4,690
1,307
Cash and cash equivalents, end of the period
18,949
12,053
Supplemental cash flow disclosure:
Cash paid for income taxes, net
5,369
4,258
Cash paid for interest
161
See accompanying Notes to Condensed Consolidated Financial Statements.
Table of Contents
Apple Inc.
Notes to Condensed Consolidated Financial Statements (Unaudited)
Note 1 Summary of Significant Accounting Policies
Apple Inc. and its wholly-owned subsidiaries (collectively Apple or the Company ) designs,
manufactures, and markets mobile communication and media devices, personal computers, and portable digital music players, and sells a variety of related software, services, peripherals, networking solutions, and third-party digital content and
applications. The Company sells its products worldwide through its retail stores, online stores, and direct sales force, as well as through third-party cellular network carriers, wholesalers, retailers and value-added resellers. In addition, the
Company sells a variety of third-party iPhone, iPad, Mac, and iPod compatible products, including application software, and various accessories through its online and retail stores. The Company sells to consumers; small and mid-sized businesses; and
education, enterprise and government customers.
Basis of Presentation and Preparation
The accompanying condensed consolidated financial statements include the accounts of the Company. Intercompany accounts and transactions
have been eliminated. The preparation of these condensed consolidated financial statements in conformity with U.S. generally accepted accounting principles ( GAAP ) requires management to make estimates and assumptions that affect the
amounts reported in these condensed consolidated financial statements and accompanying notes. Actual results could differ materially from those estimates.
These condensed consolidated financial statements and accompanying notes should be read in conjunction with the Company s annual consolidated financial statements and the notes thereto for the fiscal
year ended September 28, 2013, included in its Annual Report on Form 10-K (the 2013 Form 10-K ). The Company s fiscal year is the 52 or 53-week period that ends on the last Saturday of September. An additional week is included
in the first fiscal quarter approximately every six years to realign fiscal quarters with calendar quarters. The Company s fiscal years 2014 and 2013 each include 52 weeks. Unless otherwise stated, references to particular years, quarters or
months refer to the Company s fiscal years ended in September and the associated quarters or months of those fiscal years.
During the first quarter of 2014, the Company adopted updated accounting standards that (i) required disclosure of additional
information about the amounts reclassified out of Accumulated Other Comprehensive Income ( AOCI ) by component and (ii) required gross and net disclosures about offsetting assets and liabilities. The adoption of these updated
standards only impacted the disclosures in the Notes to the Condensed Consolidated Financial Statements; accordingly, the adoption had no impact on the Company s financial position or results of operations. The Company has provided these
additional disclosures in this Form 10-Q in Note 8, Comprehensive Income and Note 2, Financial Instruments, respectively.
Revenue Recognition
In 2013, the Company s combined best estimates of
selling price ( ESPs ) for the unspecified software upgrade rights and the rights to receive the non-software services included with its qualifying hardware devices ranged from $5 to $25. Beginning in the first quarter of 2014, the Company
adjusted the combined ESPs for Mac from $20 to $40 to reflect additions to unspecified software upgrade rights related to expansion of bundled essential software.
Table of Contents
Earnings Per Share
Basic earnings per share is computed by dividing income available to common shareholders by the weighted-average number of shares of common stock outstanding during the period. Diluted earnings per share
is computed by dividing income available to common shareholders by the weighted-average number of shares of common stock outstanding during the period increased to include the number of additional shares of common stock that would have been
outstanding if the potentially dilutive securities had been issued. Potentially dilutive securities include outstanding stock options, shares to be purchased under the Company s employee stock purchase plan and unvested restricted stock units
( RSUs ). The dilutive effect of potentially dilutive securities is reflected in diluted earnings per share by application of the treasury stock method. Under the treasury stock method, an increase in the fair market value of the
Company s common stock can result in a greater dilutive effect from potentially dilutive securities.
The following table
shows the computation of basic and diluted earnings per share for the three- and six-month periods ended March 29, 2014 and March 30, 2013 (in thousands, except net income in millions and per share amounts):
Three Months Ended
Six Months Ended
March 29,
2014
March 30,
2013
March 29,
2014
March 30,
2013
Numerator:
Net income
10,223
9,547
23,295
22,625
Denominator:
Weighted-average shares outstanding
874,757
939,629
885,415
939,273
Effect of dilutive securities
4,771
6,406
5,075
7,353
Weighted-average diluted shares
879,528
946,035
890,490
946,626
Basic earnings per share
11.69
10.16
26.31
24.09
Diluted earnings per share
11.62
10.09
26.16
23.90
Potentially dilutive securities, the effect of which would have been antidilutive, were not significant
for the three- and six-month periods ended March 29, 2014 and the three- and six-month periods ended March 30, 2013. The Company excluded these securities from the computation of diluted earnings per share.
Table of Contents
Note 2 Financial Instruments
Cash, Cash Equivalents and Marketable Securities
The following tables show the Company s cash and available-for-sale securities adjusted cost, gross unrealized
gains, gross unrealized losses and fair value by significant investment category recorded as cash and cash equivalents or short- or long-term marketable securities as of March 29, 2014 and September 28, 2013 (in millions):
March 29, 2014
Adjusted
Cost
Unrealized
Gains
Unrealized
Losses
Fair
Value
Cash and
Cash
Equivalents
Short-Term
Marketable
Securities
Long-Term
Marketable
Securities
Cash
10,948
10,948
10,948
Level 1 (a):
Money market funds
3,203
3,203
3,203
Mutual funds
4,063
(213
3,850
3,850
Subtotal
7,266
(213
7,053
3,203
3,850
Level 2 (b):
U.S. Treasury securities
24,645
12
(26
24,631
1,359
5,445
17,827
U.S. agency securities
10,766
(24
10,747
234
1,340
9,173
Non-U.S. government securities
6,406
42
(109
6,339
10
480
5,849
Certificates of deposit and time deposits
3,344
3,344
1,735
771
838
Commercial paper
2,627
2,627
1,350
1,277
Corporate securities
63,575
351
(145
63,781
110
8,373
55,298
Municipal securities
4,117
32
(3
4,146
839
3,307
Mortgage- and asset-backed securities
17,004
34
(65
16,973
26
16,947
Subtotal
132,484
476
(372
132,588
4,798
18,551
109,239
Total
150,698
476
(585
150,589
18,949
22,401
109,239
September 28, 2013
Adjusted
Cost
Unrealized
Gains
Unrealized
Losses
Fair
Value
Cash and
Cash
Equivalents
Short-Term
Marketable
Securities
Long-Term
Marketable
Securities
Cash
8,705
8,705
8,705
Level 1 (a):
Money market funds
1,793
1,793
1,793
Mutual funds
3,999
(197
3,802
3,802
Subtotal
5,792
(197
5,595
1,793
3,802
Level 2 (b):
U.S. Treasury securities
27,642
24
(47
27,619
431
7,554
19,634
U.S. agency securities
16,878
12
(52
16,838
177
3,412
13,249
Non-U.S. government securities
5,545
35
(137
5,443
50
313
5,080
Certificates of deposit and time deposits
2,344
2,344
1,264
844
236
Commercial paper
2,998
2,998
1,835
1,163
Corporate securities
54,586
275
(252
54,609
8,077
46,532
Municipal securities
6,257
45
(22
6,280
1,114
5,162
Mortgage- and asset-backed securities
16,396
23
(89
16,330
16,322
Subtotal
132,646
414
(599
132,461
3,761
22,485
106,215
Total
147,143
414
(796
146,761
14,259
26,287
106,215
(a)
The fair value of Level 1 securities is estimated based on quoted prices in active markets for identical assets or liabilities.
(b)
The fair value of Level 2 securities is estimated based on observable inputs other than quoted prices in active markets for identical assets and
liabilities, quoted prices for identical or similar assets or liabilities in inactive markets, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.
Table of Contents
The Company may sell certain of its marketable securities prior to their stated maturities
for strategic reasons including, but not limited to, anticipation of credit deterioration and duration management. The net realized gains or losses recognized by the Company related to such sales were not significant during the three- and six-month
periods ended March 29, 2014 and March 30, 2013. The maturities of the Company s long-term marketable securities generally range from one to five years.
As of March 29, 2014 and September 28, 2013, gross unrealized losses related to individual securities that had been in a continuous loss position for 12 months or longer were not significant.
As of March 29, 2014, the Company considers the declines in market value of its marketable securities investment
portfolio to be temporary in nature and does not consider any of its investments other-than-temporarily impaired. The Company typically invests in highly-rated securities, and its investment policy limits the amount of credit exposure to any one
issuer. The policy generally requires investments to be investment grade, with the primary objective of minimizing the potential risk of principal loss. Fair values were determined for each individual security in the investment portfolio. When
evaluating an investment for other-than-temporary impairment the Company reviews factors such as the length of time and extent to which fair value has been below its cost basis, the financial condition of the issuer and any changes thereto, changes
in market interest rates, and the Company s intent to sell, or whether it is more likely than not it will be required to sell the investment before recovery of the investment s cost basis. During the three- and six-month periods ended
March 29, 2014 and March 30, 2013, the Company did not recognize any significant impairment charges.
Derivative Financial
Instruments
The Company uses derivatives to partially offset its business exposure to foreign currency and interest rate
risk. The Company may enter into forward contracts, option contracts, swaps, or other derivative instruments to offset some of the risk on expected future cash flows, on net investments in certain foreign subsidiaries, and on certain existing assets
and liabilities.
To help protect gross margins from fluctuations in foreign currency exchange rates, certain of the
Company s subsidiaries whose functional currency is the U.S. dollar hedge a portion of forecasted foreign currency revenue. The Company s subsidiaries whose functional currency is not the U.S. dollar and who sell in local currencies may
hedge a portion of forecasted inventory purchases not denominated in the subsidiaries functional currencies. The Company typically hedges portions of its forecasted foreign currency exposure associated with revenue and inventory purchases,
typically for up to 12 months.
To help protect the net investment in a foreign operation from adverse changes in foreign
currency exchange rates, the Company may enter into foreign currency forward and option contracts to offset the changes in the carrying amounts of these investments due to fluctuations in foreign currency exchange rates.
To help protect against adverse fluctuations in interest rates, the Company may enter into interest rate swaps, options, or other
instruments to offset a portion of the changes in income or expense due to fluctuations in interest rates.
The Company may
also enter into foreign currency forward and option contracts to partially offset the foreign currency exchange gains and losses generated by the re-measurement of certain assets and liabilities denominated in non-functional currencies. However, the
Company may choose not to hedge certain foreign currency exchange exposures for a variety of reasons including, but not limited to, accounting considerations and the prohibitive economic cost of hedging particular exposures. There can be no
assurance the hedges will offset more than a portion of the financial impact resulting from movements in foreign currency exchange rates.
The Company records all derivatives in the Condensed Consolidated Balance Sheets at fair value. The Company s accounting treatment for these instruments is based on whether the instruments are
designated as hedge or non-hedge instruments. The effective portions of cash flow hedges are recorded in AOCI until the hedged item is recognized in earnings. The effective portions of net investment hedges are recorded in other comprehensive income
( OCI ) as a part of the cumulative translation adjustment. The ineffective portions of cash flow hedges and net investment hedges are recorded in other income and expense. Derivatives that are not designated as hedging instruments are
adjusted to fair value through earnings in the financial statement line item to which the derivative relates.
Deferred gains
and losses associated with cash flow hedges of foreign currency revenue are recognized as a component of net sales in the same period as the related revenue is recognized, and deferred gains and losses related to cash flow hedges of inventory
purchases are recognized as a component of cost of sales in the same period as the related costs are recognized. Deferred gains and losses associated with cash flow hedges of interest income or expense are recognized as a component of other
income/(expense), net in the same period as the related income or expense is recognized. The Company s hedged foreign currency transactions and hedged interest rate transactions as of March 29, 2014 are expected to occur within 12 months